Taxol and CD95 Ligand Work Together to Kill Brain Cancer Cells
Author Information
Author(s): W Roth, B Wagenknecht, C Grimmel, J Dichgans, M Weller
Primary Institution: University of Tubingen, School of Medicine
Hypothesis
Does the combination of taxol and CD95 ligand enhance the apoptosis of human malignant glioma cells?
Conclusion
The study found that taxol and CD95 ligand work together to significantly increase the death of malignant glioma cells.
Supporting Evidence
- Taxol and CD95 ligand showed significant synergistic cytotoxicity and growth inhibition.
- High concentrations of taxol induced G/M cell cycle arrest, but synergy was achieved at lower concentrations.
- Taxol induced bcl-2 phosphorylation, which may sensitize glioma cells to CD95 ligand.
Takeaway
This study shows that using two treatments together, taxol and CD95 ligand, can help kill brain cancer cells better than using either one alone.
Methodology
The study involved treating human malignant glioma cell lines with taxol and CD95 ligand, assessing cell viability and apoptosis through various assays.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website